| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1395500 |
Metaproterenol Sulfate (200 mg) |
5874-97-5 |
|
| 2922504500 |
|
|
|
| USP-1396003 |
Metaraminol Bitartrate (200 mg) |
33402-03-8 |
UN2811 |
| USP-1396036 |
Metaraminol Related Compound A (25 mg) ((E)-1-[3-(benzyloxy)phenyl]-2-(hydroxyimino)propan-1-one) |
N/A |
|
| 2925294500 |
|
|
|
| USP-1396047 |
Metaraminol Related Compound B (25 mg) (2-Amino-1-[3-(benzyloxy)phenyl]propan-1-ol) |
1940-82-5 |
|
| 2922504500 |
|
|
|
| USP-1396058 |
Metaraminol Enantiomer (25 mg) (3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate) |
27303-40-8 |
|
| 2939800000 |
|
|
|
| USP-1396149 |
Metaxalone (200 mg) |
1665-48-1 |
|
| 2934990005 |
|
|
|
| USP-1396150 |
Metaxalone Related Compound A (10 mg) (4-((3,5-dimethylphenoxy)methyl)imidazolidin-2-one) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1396168 |
Metaxalone Related Compound B (25 mg) (1-amino-3-(3,5-dimethylphenoxy)propan-2-ol) |
66766-07-2 |
|
| 2921490002 |
|
|
|
| USP-1396171 |
Metaxalone Related Compound C (25 mg) (Bis[2-hydroxy-3-(3,5-dimethylphenoxy)propyl]amine) |
805972-34-3 |
|
| 2921490002 |
|
|
|
| USP-1396309 |
Metformin Hydrochloride (200 mg) |
1115-70-4 |
|
| 2925299000 |
|
|
|
| USP-1428229 |
Methylene Simvastatin (30 mg) ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate) |
1449248-72-9 |
|
| 2932206000 |
|
|
|
| USP-1429113 |
Methylenediurea (300 mg) (1,1′-Methylenediurea) |
13547-17-6 |
|
| 2924190002 |
|
|
|
| USP-1430000 |
Methylergonovine Maleate (50 mg) |
57432-61-8 |
UN1544 |
| USP-1430509 |
3-O-Methylmethyldopa (50 mg) |
N/A |
|
| 2922504500 |
|
|
|
| USP-1430735 |
Methylnaltrexone Bromide (100 mg) |
73232-52-7 |
|
| 2939190000 |
|
|
|
| USP-1430815 |
6-Methylnicotinic Acid (50 mg) |
3222-47-7 |
|
| 2933399095 |
|
|
|
| USP-1430917 |
Methyl 12-Hydroxystearate (200 mg) |
141-23-1 |
|
| 2918195000 |
|
|
|
| USP-1431603 |
Methyl Palmitate (3 x 100 mg) |
112-39-0 |
|
| 2915700100 |
|
|
|
| USP-1432005 |
Methylparaben (125 mg) |
99-76-3 |
|
| 2918290000 |
|
|
|
| USP-1434022 |
Methylphenidate Related Compound A (50 mg) (alpha-Phenyl-2-piperidineacetic Acid Hydrochloride) |
19395-40-5 |
|
| 2933399095 |
|
|
|
| USP-1435003 |
Methylprednisolone (200 mg) |
83-43-2 |
|
| 2937290000 |
|
|
|
| USP-1435014 |
Methylprednisolone Related Compound A (25 mg) (17,21-Dihydroxy-6alpha-methylpregna-1,4-diene-3,11,20-trione) |
91523-05-6 |
|
| 2937290000 |
|
|
|
| USP-1435036 |
Methylprednisolone Related Compound C (25 mg) (11beta-Hydroxy-6alpha-methylandrosta-1,4-diene-3,17-dione) |
61919-52-6 |
|
| 2937290000 |
|
|
|
| USP-1436006 |
Methylprednisolone Acetate (200 mg) |
53-36-1 |
|
| 2937290000 |
|
|
|
| USP-1436028 |
Methylprednisolone System Suitability Mixture (25 mg) |
NA |
|
| 3822190000 |
|
|
|
| USP-1437009 |
Methylprednisolone Hemisuccinate (250 mg) |
2921-57-5 |
|
| 2937290000 |
|
|
|
| USP-1623671 |
Sulbactam Sodium (100 mg) |
69388-84-7 |
|
| 2934990005 |
|
|
|
| USP-1623681 |
Sulconazole Nitrate (200 mg) |
61318-91-0 |
|
| 2933290000 |
|
|
|
| USP-1623692 |
Sulconazole Related Compound A (15 mg) (1-[2-(4-Chlorobenzyl)sulfinyl-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate) |
77279-29-9 |
|
| 2933290000 |
|
|
|
| USP-1623749 |
Sulbactam Related Compound A (15 mg) ((2S)-2-Amino-3-methyl-3-sulfinobutanoic acid) |
23315-18-6 |
|
| 2930909265 |
|
|
|
| USP-1623772 |
Sulbactam Related Compound D (15 mg) (Potassium (2S,5R,6R)-6-bromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate) |
4027-64-9 |
|
| 2941906000 |
|
|
|
| USP-1623783 |
Sulbactam Related Compound E (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide) |
76646-91-8 |
|
| 2941906000 |
|
|
|
| USP-1623794 |
Sulbactam Related Compound F (15 mg) ((2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid) |
24158-88-1 |
|
| 2941906000 |
|
|
|
| USP-1624006 |
Sulfacetamide Sodium (500 mg) |
6209-17-2 |
|
| 2935904000 |
|
|
|
| USP-1624505 |
Sulfachlorpyridazine (200 mg) |
80-32-0 |
|
| 2935909550 |
|
|
|
| USP-1625009 |
Sulfadiazine (200 mg) |
68-35-9 |
|
| 2935904000 |
|
|
|
| USP-1626001 |
Sulfadimethoxine (200 mg) |
122-11-2 |
|
| 2935904000 |
|
|
|
| USP-1626500 |
Sulfadoxine (200 mg) |
2447-57-6 |
UN3077 |
| USP-1628007 |
Sulfamerazine (500 mg) |
127-79-7 |
|
| 2935904000 |
|
|
|
| USP-1629000 |
Sulfamethazine (1 g) |
57-68-1 |
|
| 2935904000 |
|
|
|
| USP-1629019 |
Sulfamethazine Related Compound A (100 mg) (4-Amino-N-carbamimidoylbenzenesulfonamide-, monohydrate) |
6190-55-2 |
|
| 2935909550 |
|
|
|
| USP-1629021 |
Sulfamethazine Related Compound B (50 mg) (Mixture containing about 49% of 4-Amino-2-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide and about 48% of 4-Amino-3-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide) |
N/A |
|
| 2935909550 |
|
|
|
| USP-1630009 |
Sulfamethizole (200 mg) |
144-82-1 |
|
| 2935904000 |
|
|
|
| USP-1631001 |
Sulfamethoxazole (200 mg) |
723-46-6 |
UN3077 |
| USP-1631500 |
Sulfamethoxazole N4-Glucoside (25 mg) (4-(beta-D-glucopyranosylamino)-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide) |
119691-75-7 |
|
| 2935909550 |
|
|
|
| USP-1631511 |
Sulfamethoxazole Related Compound A (15 mg) (N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}acetamide) |
21312-10-7 |
|
| 2935909550 |
|
|
|
| USP-1631522 |
Sulfamethoxazole Related Compound B (15 mg) (4-amino-N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}benzenesulfonamide) |
135529-16-7 |
|
| 2935909550 |
|
|
|
| USP-1631533 |
Sulfamethoxazole Related Compound C (15 mg) (5-methylisoxazol-3-amine) |
1072-67-9 |
|
| 2934990005 |
|
|
|
| USP-1631566 |
Sulfamethoxazole Related Compound F (15 mg) (4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide) |
17103-52-5 |
|
| 2935909550 |
|
|
|
| USP-1632004 |
Sulfanilamide (5 g) |
63-74-1 |
|
| 2935904000 |
|
|
|
| USP-1633007 |
Sulfanilamide Melting Point Standard (1 g) (Approximately 165 degrees) |
63-74-1 |
|
| 2935904000 |
|
|
|
| USP-1633506 |
Sulfanilic Acid (200 mg) (4-Aminobenzenesulfonic acid) |
121-57-3 |
|
| 2921420000 |
|
|
|
| USP-1634000 |
Sulfapyridine (200 mg) |
144-83-2 |
|
| 2935904000 |
|
|
|
| USP-1635206 |
Sulfaquinoxaline (200 mg) |
59-40-5 |
|
| 2935904000 |
|
|
|
| USP-1635228 |
Sulfaquinoxaline Related Compound A (25 mg) (N1,N2-diquinoxalin-2-ylsulfanilamide) |
N/A |
|
| 2935909550 |
|
|
|
| USP-1636005 |
Sulfasalazine (125 mg) |
599-79-1 |
|
| 2935904000 |
|
|
|
| USP-1636118 |
Sulfasalazine Related Compound K (25 mg) (5-{4-[N-(6-Methylpyridin-2-yl)sulfamoyl]phenyldiazenyl}salicylic acid) |
42753-55-9 |
|
| 2935909550 |
|
|
|
| USP-1636504 |
Sulfathiazole (350 mg) |
72-14-0 |
|
| 2935904000 |
|
|
|
| USP-1638000 |
Sulfisoxazole (200 mg) |
127-69-5 |
|
| 2935904000 |
|
|
|
| USP-1639003 |
Sulfisoxazole Acetyl (200 mg) |
80-74-0 |
|
| 2935904000 |
|
|
|
| USP-1642008 |
Sulindac (200 mg) |
38194-50-2 |
UN2811 |
| USP-1642019 |
Sulindac Related Compound A (20 mg) ((E)-2-{5-Fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid) |
53933-60-1 |
|
| 2930902000 |
|
|
|
| USP-1642020 |
Sulindac Related Compound B (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-inden-3-yl}acetic acid) |
59973-80-7 |
|
| 2930902000 |
|
|
|
| USP-1642031 |
Sulindac Related Compound C (20 mg) ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylthio)benzylidene]-1H-inden-3-yl}acetic acid) |
49627-27-2 |
|
| 2930902000 |
|
|
|
| USP-1642100 |
Sulisobenzone (500 mg) |
4065-45-6 |
|
| 2914500000 |
|
|
|
| USP-1642154 |
Sumatriptan (50 mg) |
103628-46-2 |
|
| 2935904000 |
|
|
|
| USP-1642201 |
Sumatriptan Succinate (200 mg) |
103628-48-4 |
|
| 2935904000 |
|
|
|
| USP-1642212 |
Sumatriptan Succinate Related Compound A (15 mg) ([3-[2-(dimethylamino)ethyl]-2-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-N-methylmethanesulfonamide, succinate salt) |
N/A |
|
| 2935909550 |
|
|
|
| USP-1642223 |
Sumatriptan Succinate Related Compound C (50 mg) ([3-[2-(dimethylamino)ethyl]-1-(hydroxymethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt) |
N/A |
|
| 2935909550 |
|
|
|
| USP-1642256 |
Sumatriptan Succinate Related Impurities (25 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1642358 |
Sunitinib Malate (200 mg) |
341031-54-7 |
UN3077 |
| USP-1642507 |
Suprofen (200 mg) |
40828-46-4 |
UN2811 |
| USP-1642609 |
Synephrine (30 mg) |
1994/7/5 |
|
| 2939800000 |
|
|
|
| USP-1642802 |
Tacrolimus (150 mg) |
109581-93-3 |
UN2811 |
| USP-1642813 |
Tacrolimus Related Compound A (15 mg) (See USP Certificate for full Chemical Name) |
135635-46-0 |
|
| 2934990005 |
|
|
|
| USP-1282707 |
Fondaparinux Sodium for Assay (0.6 mL) (需冷链运输) |
114870-03-0 |
|
| 2932999000 |
|
|
|
| USP-1304016 |
Heparin Sodium for Assays (9.5 mg) (需冷链运输) |
9041/8/1 |
|
| 3001900190 |
|
|
|
| USP-1342059 |
Insulin Glargine (15.27 mg) (需冷链运输) |
160337-95-1 |
|
| 2937190000 |
|
|
|
| USP-1342060 |
Insulin Glargine for Peak Identification (3.2 mg) (Mixture of Insulin Glargine and 0A-Arg-Insulin Glargine) (需冷链运输) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1342150 |
High Molecular Weight Insulin Human (8.4 mg) (需冷链运输) |
11061-68-0 |
|
| 2937120000 |
|
|
|
| USP-1365043 |
Levothyroxine Peak Identification Mixture (3 x 5 mL) (1 mg/mL) (需冷链运输) |
N/A |
UN1230 |
| USP-1430349 |
Methyl Linolenate (5 x 50 mg) (需冷链运输) |
301-00-8 |
|
| 2916151000 |
|
|
|
| USP-1445550 |
Monoclonal IgG System Suitability (2 mg) (需冷链运输) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1499414 |
Paricalcitol Solution (3 mL) (需冷链运输) |
N/A |
UN1170 |
| USP-1500626 |
Pegfilgrastim for Bioassay (需冷链运输) |
208265-92-3 |
|
| 3002140000 |
|
|
|
| USP-1526030 |
Phenoxybenzamine Nitrile (50 mg) (需冷链运输) (3-[Benzyl(1-phenoxypropan-2-yl)amino]propanenitrile) |
N/A |
|
| 2926900005 |
|
|
|
| USP-1548098 |
Pomegranate Juice Concentrate (5 x 1 mL) |
N/A |
|
| 2009899100 |
|
|
|
| USP-1180026 |
Dextroamphetamine Related Compound B CII (25 mg) (Phenyl acetone) |
103-79-7 |
|
| 2914310000 |
|
|
|
| USP-1258305 |
Ethchlorvynol CIV (0.7 mL) |
113-18-8 |
UN2810 |
| USP-1359506 |
Levmetamfetamine CII (75 mg) |
33817-09-3 |
|
| 2921490002 |
|
|
|
| USP-1496959 |
Paraldehyde CIV (3 x 1.5 mL) |
123-63-7 |
|
| 2912505000 |
|
|
|
| USP-1342401 |
Interferon Beta-1A (1.0 mL) (国际冷链运输要求) |
145258-61-3 |
|
| 3002130000 |
|
|
|
| USP-1445539 |
USP mAb 001, Monoclonal IgG1 (国际冷链运输要求) |
174722-31-7 |
|
| 3002130000 |
|
|
|
| USP-1445547 |
USP mAb 002, Monoclonal IgG1 (国际冷链运输要求) |
216974-75-3 |
|
| 3002130000 |
|
|
|
| USP-1445595 |
USP mAb 003, Monoclonal IgG1 (国际冷链运输要求) |
912628-39-8 |
|
| 3002130000 |
|
|
|
| USP-1667643 |
Tigecycline (300 mg) (国际冷链运输要求) |
220620-09-7 |
UN3077 |
| USP-1211200 |
Dimethylamine Solution (6 x 3 mL) (International Restricted Sales Item) |
124-40-3 (Dimethylamine) |
UN1160 |
| USP-1050905 |
Benzaldehyde (3 X 1 mL) (List Chemical) |
100-52-7 |
UN1990 |
| USP-1082592 |
Butyl Anthranilate (1 mL) (List Chemical) |
7756-96-9 |
|
| 2922493800 |
|
|
|
| USP-1381742 |
Meradimate (500 mg/ampule) (Menthyl Anthranilate) (List Chemical) |
134-09-8 |
|
| 2922493800 |
|
|
|
